NO20053357L - Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse. - Google Patents

Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse.

Info

Publication number
NO20053357L
NO20053357L NO20053357A NO20053357A NO20053357L NO 20053357 L NO20053357 L NO 20053357L NO 20053357 A NO20053357 A NO 20053357A NO 20053357 A NO20053357 A NO 20053357A NO 20053357 L NO20053357 L NO 20053357L
Authority
NO
Norway
Prior art keywords
myoblasts
stem cells
progenitor
culture medium
culture
Prior art date
Application number
NO20053357A
Other languages
English (en)
Other versions
NO20053357D0 (no
Inventor
Christian Pinset
Original Assignee
Celogos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celogos filed Critical Celogos
Publication of NO20053357L publication Critical patent/NO20053357L/no
Publication of NO20053357D0 publication Critical patent/NO20053357D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Det beskrives et preparat for et dyrkingsmedium for progenitor-Zstamceller avledet fra muskelvev, inneholdende serum og/eller serum fraksjoner av human opprinnelse og/eller animalsk opprinnelse, insulin eller et derivat derav, og en eller flere forbindelser valgt fra klassen antioksidanter og/eller vitaminer. Det beskrives videre en fremgangsmåte for dyrking av progenitor-Zstamceller, en fremgangsmåte for fremstilling av myoblaster som kan benyttes som cellulært/genetisk terapiprodukt. Det tas sikte på å optimalisere produksjonen av myoblaster fra progenitor-stamceller.
NO20053357A 2002-12-13 2005-07-11 Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse. NO20053357D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0215827 2002-12-13
PCT/FR2003/003691 WO2004055174A1 (fr) 2002-12-13 2003-12-12 Composition de milieu de culture, procede de culture, et myoblastes ainsi obtenus, et leurs utilisations

Publications (2)

Publication Number Publication Date
NO20053357L true NO20053357L (no) 2005-07-11
NO20053357D0 NO20053357D0 (no) 2005-07-11

Family

ID=32524649

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053357A NO20053357D0 (no) 2002-12-13 2005-07-11 Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse.

Country Status (16)

Country Link
US (1) US20060258003A1 (no)
EP (1) EP1572988A1 (no)
JP (1) JP2006509516A (no)
KR (1) KR20050088118A (no)
CN (1) CN1723277A (no)
AU (1) AU2003300585A1 (no)
BR (1) BR0316757A (no)
CA (1) CA2509642A1 (no)
IL (1) IL169115A0 (no)
MX (1) MXPA05006350A (no)
NO (1) NO20053357D0 (no)
NZ (1) NZ540723A (no)
PL (1) PL378334A1 (no)
RU (1) RU2005122030A (no)
WO (1) WO2004055174A1 (no)
ZA (1) ZA200505125B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100679642B1 (ko) * 2005-11-16 2007-02-06 주식회사 알앤엘바이오 인간 지방조직 유래 다분화능 줄기세포 및 이를 함유하는세포치료제
EP2029771A4 (en) * 2006-06-12 2010-08-04 Zora Biosciences Oy DIAGNOSTIC METHOD OF MYOPATHY
US20100092432A1 (en) * 2006-08-08 2010-04-15 Takenori Ozaki Cell preparation containing multipotential stem cells originating in fat tissue
EP1900810A1 (fr) * 2006-09-15 2008-03-19 Celogos Methode d'extraction et de selection de cellules
US20080208164A1 (en) 2007-02-28 2008-08-28 Innovacell Biotechnologie Gmbh Methods for the treatment of anal incontinence
US20090042296A1 (en) * 2007-03-16 2009-02-12 Marie Callahan Transfection ready eukaryotic cells
CA2691361A1 (en) * 2007-06-15 2008-12-24 Ethicon, Inc. Tissue fragment compositions for the treatment of incontinence
CN101386836B (zh) * 2007-09-12 2010-11-24 北京清大天一科技有限公司 动物细胞培养基干粉组合物、培养基组合物及其制备方法
ES2360782B1 (es) 2009-07-28 2012-03-12 Grifols, S.A. Medios para cultivo de células de mamíferos que comprenden sobrenadante de etapas del fraccionamiento de Cohn y uso de los mismos.
EP2397851B1 (fr) 2010-06-21 2015-01-07 Centre d'Etude des Cellules Souches Méthode de sélection des modulateurs de la synthèse de mévalonate en utilisant des cellules dérivées de cellules pluripotentes humaines
JP2012029623A (ja) * 2010-07-30 2012-02-16 Bio Link Inc 細胞分離用酵素溶液及び細胞分離方法、並びに膵島分離方法
WO2014044867A1 (en) * 2012-09-24 2014-03-27 Innovacell Biotechnologie Ag Potency assay for skeletal muscle derived cells
US10167448B2 (en) 2013-12-12 2019-01-01 Samsung Life Public Welfare Foundation Pharmaceutical composition for treating cerebrovascular diseases, containing stem cell-derived exosome as active ingredient
JP6553046B2 (ja) * 2013-12-18 2019-07-31 シィトーＣｙｔｏｏ 筋芽細胞の筋管への分化を規格化するための装置および方法
RU2576842C2 (ru) * 2014-02-28 2016-03-10 Общество С Ограниченной Ответственностью "Витацел" Способ получения миобластов, использование биоптата десны, препарат миобластов для лечения патологий мышечной ткани и способ его получения
WO2015142061A1 (ko) 2014-03-18 2015-09-24 사회복지법인 삼성생명공익재단 줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌 염증성 질환의 치료용 조성물
BR112016027797A2 (pt) 2014-06-18 2017-10-31 Medimmune Llc métodos e meios de cultura de células compreendendo n-acetilcisteína
KR101960497B1 (ko) * 2016-05-09 2019-03-21 고려대학교 산학협력단 소변 유래 세포 배양용 배지 조성물
KR20200071061A (ko) * 2017-07-15 2020-06-18 알레프 팜스 리미티드 배양된 육류 조성물
AU2020221966B2 (en) * 2019-02-13 2025-07-31 Takeda Pharmaceutical Company Limited Cryopreservation of stem cells
CN112592890A (zh) * 2020-12-17 2021-04-02 江南大学 一种促进肌肉干细胞增殖的方法
WO2022211461A1 (ko) * 2021-03-29 2022-10-06 협성대학교산학협력단 근육줄기세포 증식을 위한 강황, 글라이신 또는 인슐린을 포함하는 근육줄기세포 배양용 배지 조성물
CN114752590B (zh) * 2022-01-14 2023-09-08 江南大学 一种高效且经济的猪肌肉干细胞的分离方法及其应用
CN117625519B (zh) * 2022-08-12 2025-03-25 江南大学 促肌肉干细胞体外存活和增殖的无胎牛血清培养基及其应用
CN117925509B (zh) * 2024-03-25 2024-06-11 山东三链医疗科技有限公司 一种细胞培养替代血清培养液及方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7984498A (en) * 1997-06-25 1999-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Serum-free cell growth medium

Also Published As

Publication number Publication date
CN1723277A (zh) 2006-01-18
ZA200505125B (en) 2006-03-29
AU2003300585A1 (en) 2004-07-09
RU2005122030A (ru) 2005-12-20
IL169115A0 (en) 2007-07-04
NZ540723A (en) 2008-04-30
CA2509642A1 (fr) 2004-07-01
KR20050088118A (ko) 2005-09-01
MXPA05006350A (es) 2006-02-08
WO2004055174A1 (fr) 2004-07-01
US20060258003A1 (en) 2006-11-16
JP2006509516A (ja) 2006-03-23
PL378334A1 (pl) 2006-03-20
EP1572988A1 (fr) 2005-09-14
BR0316757A (pt) 2005-10-25
NO20053357D0 (no) 2005-07-11

Similar Documents

Publication Publication Date Title
MXPA05006350A (es) Composicion de medio de cultivo, procedimiento de cultivo y mioblastos obtenidos y sus utilizaciones.
WO2006073846A3 (en) Methods for expression and purification of recombinant human growth hormone
CY1107771T1 (el) Μεθοδος για την παραγωγη χονδρινων εμφυτευματων απο in vitro καλλιεργημενα χονδροκυτταρα
EP2292664A3 (en) Multispecific deimmunized CD3-binders
CY1118167T1 (el) Πρωτογενη και εγγυς ηπατικα βλαστοκυτταρα
WO2021030617A3 (en) Improved oligosaccharide production in yeast
WO2013058594A3 (ko) 항염 활성을 갖는 발효녹용 추출물의 제조 방법, 이로부터 얻어진 추출물 및 이러한 추출물의 용도
NO20050703L (no) Fremgangsmate for fremstilling av ketokarotinoider i genetisk modifiserte organismer
MX2021005948A (es) Biosintesis de compuestos en levadura.
DE60041821D1 (de) Pluripotent embryonale stammzellen-ähnliche zellen, zusammensetzungen und ihre vervendungen
ATE326523T1 (de) Verfahren zur fermentativen herstellung von l- methionin
WO2010080530A3 (en) Plant cell culture for production of natural products with reduced glucosinolate contamination
NO20061470L (no) Fremgangsmate for fremstilling av gamma-karboksylerte proteiner
WO2008102253A3 (en) Method of biosynthesizing tetrodotoxin
DK1776451T3 (da) Fremgangsmåde til fremstilling af L-aminosyrer under anvendelse af stammer fra familien enterobacteriaceae
ATE353953T1 (de) Wirtszelle, die reduzierte mengen einer metalloprotease exprimiert und methoden zur verwendung dieser wirtszelle zur proteinproduktion
WO2018183848A8 (en) Media for microorganism culture and related compositions and methods
DK1554374T3 (da) Fremgangsmåde til storskala T-lymfocytdyrkning i et homogent system
CN103141391A (zh) 一种西洋参不定根组织培养方法
DE50301559D1 (de) Verfahren zur herstellung von tocotrienol-angereicherten präparationen
WO2002086137A3 (en) Process for the production of l-amino acids by fermentation using coryneform bacteria
WO2001029204A3 (en) Protein production system
WO2007089950A3 (en) Preparations of growth hormone
WO2005054447A3 (en) Müller stem cells
NO20073483L (no) Peptidfraksjoner som fremmer vekst og syntese av onsket produkt(er) inn i celle og/eller vevskultur

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application